Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
Justice Is Served: Stolen Dog Immediately Recognizes Owner In Court Room
Mom Asks To Reschedule Solar Eclipse And We Can't Stop Laughing
There Are 16 Circles In This Image. Can You Spot Them?
People Tried To Call This Tea Party Racist, Then A Japanese Woman Stepped In And Set The Record Straight
Flooring Company Owner Posts Photos Of Dogs As 'Employee Of The Week'
The Last Blockbuster Has A Twitter Account And Their Tweets Are Hilarious
Justice Is Served: Stolen Dog Immediately Recognizes Owner In Court Room
Dog Squirts Sea Water Out Of His Butt Every Time He Barks
This Is Probably The Best 30 Seconds Of TV Ever Filmed
Adorable Baby Otter Misses Her Human, Demands Cuddles
A Southern Man Tries To Speak Without An Accent. Absolutely Hilarious!
